Future study of WNT4 in ovarian cancer biology (and other gynecologic cancers) are critical to link WNT4 genotype to cancer risk, patient prognosis, therapy response, patient outcomes, and cancer health disparities. Here, WNT4 is linked to ovarian carcinoma.